Bowel Cancer and Biomarker Research Lab
Bowel cancer, also known as colorectal cancer, is the second most common cancer in Australian men and women. It affects 1 in 13 people. It is also Australia’s second deadliest cancer, with over 5,000 people dying each year. Early detection through screening can improve survival rates, however further research is needed to help find cures and prevent the disease.
The Bowel Cancer and Biomarker Laboratory at the Kolling Institute uses advanced technologies to study the genes and proteins responsible for bowel cancers growing and spreading. Our aim is to use a patient’s own molecular information to understand the risk of bowel cancer developing and to guide treatment options. As part of our research, we are studying how to control bowel polyp growth, which are precursors to cancer. We are doing this through diet and chemotherapy drugs.
Prof Mark P. Molloy, PhD | Lawrence Penn Chair of Bowel Cancer Research
The University of Sydney | Northern Clinical School
Faculty of Medicine and Health
Honorary Professor | Dept. Molecular Sciences, Macquarie University
Secretary | Australasian Proteomics Society
Dr Jun Li PhD
Postdoctoral Research Fellow
Dr Benita Tse
Research Fellow
Matthew McKay - Senior Research Officer
Bharat Venkatesh Gunappa - Research Officer
(Vo Van) Anh Pham - PhD Student
YuHong Fu - Visiting Researcher
Ping (Wendy) Wu - Visiting Research Assistant
Kiera Hicks - Honours Student
Colby Stevenson - PhD Student
Eve Hopping - Masters Student
Gabriella Parrilla - Research Assistant
Samuel Pheeney - Honours Student
(Hafiz) Saad Ahmad - PhD Student
Current bowel cancer research focuses on:
- Why and how some bowel polyps become cancers
- Which bowel tumours are likely to spread
- Molecular make-up of colorectal tumours
- Early detection of disease recurrence
Our research is facilitated by specimens from clinical projects we run including:
- Sydney 1000 bowel cancer study
- IMAP Bowel polyp study
Bowel Cancer and Biomarker Research related information
Events, News and Seminars
Prestigious grant for groundbreaking blood cancer research at the Kolling
Posted on: 07 March, 2025
A two-decade long commitment to reducing blood cancers has delivered coveted national funding to Ass..... Read more
Category: Funding support, Research Excellence
Cancer experts going from strength to strength
Posted on: 13 December, 2024
A special visit by two international cancer specialists could mark the start of a valuable collabora..... Read more
Category: Presentations, Research Excellence
Partnership to drive innovation in genomic science
Posted on: 11 December, 2024
An exciting partnership between AGRF Ltd (Australian Genome Research Facility) and the University of..... Read more
Category: New Treatment, Research Excellence